Evogene Ltd. (TLV:EVGN)
440.70
+13.20 (3.09%)
Aug 14, 2025, 5:24 PM IDT
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
215.29K ILS
Profits / Employee
-484.02K ILS
Market Cap
37.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teva Pharmaceutical Industries | 35,686 |
Danel (Adir Yeoshua) | 4,290 |
Kamada | 420 |
Bait Bakfar | 227 |
SofWave Medical | 126 |
BrainsWay | 120 |
Novolog (Pharm-Up 1966) | 936 |
Ilex Medical | 178 |
Evogene News
- 2 days ago - Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - PRNewsWire
- 16 days ago - Evogene Schedules Second Quarter 2025 Financial Results Release - PRNewsWire
- 5 weeks ago - Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - PRNewsWire
- 2 months ago - Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PRNewsWire
- 3 months ago - Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evogene GAAP EPS of -$0.38, revenue of $2.44M - Seeking Alpha
- 3 months ago - Evogene Reports First Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Evogene Q1 2025 Earnings Preview - Seeking Alpha